Select Page

Neuropsychological profile of amyloid‐positive versus amyloid‐negative amnestic Mild Cognitive Impairment

May 6, 2021 Introduction Patients diagnosed with amnestic mild cognitive impairment (aMCI) are at high risk of progressing to dementia. It became possible, through the use of biomarkers, to diagnose those patients with aMCI who have Alzheimer’s disease. However,...

Identification of undiagnosed dementia cases using a web‐based pre‐screening tool: The MOPEAD project

April 23, 2021 Abstract Introduction Innovative patient engagement models are required to identify people with prodromal and mild Alzheimer’s disease who are “hidden” in their communities and not normally found in a memory clinic setting. Methods A marketing...

Characterization of dementia with Lewy bodies (DLB) and mild cognitive impairment using the Lewy body dementia module (LBD‐MOD)

April 6, 2021 Abstract Introduction The National Institute on Aging Alzheimer’s Disease Research Center program added the Lewy body dementia module (LBD‐MOD) to the Uniform Data Set to facilitate LBD characterization and distinguish dementia with Lewy bodies...

Concomitant neurodegenerative pathologies contribute to the transition from mild cognitive impairment to dementia

March 5, 2021 Abstract Introduction The aged brain frequently exhibits multiple pathologies, rather than a single hallmark pathology (pure pathology [PurP]), ranging from low/intermediate levels of additional pathology (LowP) to mixed severe pathology (mixed SevP). We...